Related Experiment Video
Updated: May 10, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
PHGDH as a therapeutic node: Natural modulators from TCM, degradation pathways, and emerging TPD strategies
Song-Song Shi1, Du Yu-Dan1, Si-Yi Chen1
1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China.
Abstract:
Phosphoglycerate dehydrogenase (PHGDH) has emerged as a promising therapeutic target due to its critical roles in the pathogenesis of cancer and neurological disorders. Targeting PHGDH holds significant theoretical and translational potential for cancer therapy and the amelioration of cognitive impairments. However, currently available PHGDH inhibitors are limited in number and primarily function through inhibition of the enzyme's catalytic activity. This review systematically summarizes PHGDH modulators identified from traditional Chinese medicine, including both inhibitors and activators, and presents a detailed analysis of their structure-activity relationships (SAR) and mechanisms of action. It also comprehensively outlines the signaling pathways that regulate PHGDH degradation through the ubiquitin-proteasome system and autophagy-lysosome pathway. Importantly, it also discusses emerging targeted protein degradation (TPD) technologies, including PROTACs, LYTACs, AUTACs, and ATTECs. The development of these frontier technologies has opened new pathways for mitigating the limitations of existing inhibitors.
Insights
This review explores phosphoglycerate dehydrogenase (PHGDH) modulators from traditional Chinese medicine. It highlights novel therapeutic strategies, including targeted protein degradation, for cancer and neurological disorders.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Phosphoglycerate dehydrogenase (PHGDH) is implicated in cancer and neurological disease pathogenesis.
- Current PHGDH inhibitors primarily target catalytic activity, with limited options available.
- PHGDH modulation offers therapeutic potential for cancer and cognitive impairment.
Purpose of the Study:
- To systematically review PHGDH modulators from traditional Chinese medicine.
- To analyze structure-activity relationships (SAR) and mechanisms of action of these modulators.
- To discuss emerging targeted protein degradation (TPD) technologies for PHGDH.
Main Methods:
- Systematic literature review of traditional Chinese medicine compounds.
- Analysis of structure-activity relationships (SAR) and mechanisms of action.
- Review of signaling pathways regulating PHGDH degradation (ubiquitin-proteasome, autophagy-lysosome).
Main Results:
- Identified various PHGDH inhibitors and activators from traditional Chinese medicine.
- Detailed SAR and mechanistic insights for identified compounds.
- Overview of PHGDH degradation pathways and their regulation.
Conclusions:
- Traditional Chinese medicine offers diverse PHGDH modulators.
- Emerging TPD technologies like PROTACs present new therapeutic avenues.
- PHGDH-targeted therapies show promise for cancer and neurological disorders.
More Related Videos
12:34Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenomics: Identification of New Drug Targets
Healing I: Introduction